Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

DECAPEPTIDE-30.

Insufficient Data / SKIN CONDITIONING

DECAPEPTIDE-30, identified primarily as a basic fibroblast growth factor (bFGF)-related decapeptide, is a specialized biomimetic peptide. It is predominantly recognized for its targeted efficacy in stimulating melanin production, serving as a therapeutic agent for conditions characterized by depigmentation.

Melanin Stimulant Repigmenting Agent

Science

This decapeptide acts by precisely stimulating the migratory behavior and proliferation of melanocytes—the skin cells responsible for producing melanin—within depigmented areas and hair roots. This activation and increase in melanocyte activity are crucial for fostering melanin synthesis, thereby aiding in the restoration of natural skin color in affected regions.


Research

High confidence
Effective range N/A
Optimal

0.1%


Transparency

Not commonly dusted

DECAPEPTIDE-30 is a highly specific therapeutic active, primarily studied for vitiligo treatment at a defined concentration (0.1%). It is not typically incorporated into general cosmetic formulations at sub-efficacious percentages for broad 'skincare benefits,' making the concept of 'dusting' less applicable to its observed use.


The Formula

Solubility
Unknown
Optimal pH N/A
0 7 14

Stability

No specific optimal pH range or detailed stability characteristics are available for this decapeptide. General peptide stability is known to be sensitive to factors such as pH, temperature, and the presence of various excipients.

Conflicts

  • Known sensitivity or allergy to any of its components
  • Application on broken, irritated, or infected skin
  • Potential interactions with other topical medications, including corticosteroids (e.g., hydrocortisone) and calcineurin inhibitors (e.g., tacrolimus)

Safety

CIR Status
Not reviewed
Sensitization risk Low

Decapeptide is generally considered safe with a favorable safety profile and good tolerability when used therapeutically for vitiligo, with no severe or fatal side effects reported in studies. Mild side effects such as dry skin and skin irritation have been noted. It has received approval for vitiligo treatment in India; however, it lacks specific CIR, SCCS, or FDA cosmetic ingredient review status.


Your Skin

No Normal
No Dry
No Oily
No Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Insufficient Data

While demonstrating high efficacy in the specific therapeutic application of vitiligo repigmentation, current data is insufficient to ascertain its broader utility or benefits within general precision skincare formulations.


Related

Finding similar ingredients…